Unlock instant, AI-driven research and patent intelligence for your innovation.

Markers for drug resistance of cancer cells, preparation compositions for reversing drug resistance of cancer cells and applications of markers

A cancer cell and marker technology, applied in the field of biomedicine, can solve problems such as PARP inhibitor insensitivity

Active Publication Date: 2021-08-06
TONGJI HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI TECH
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] However, for HRD-negative patients, which are themselves insensitive to PARP inhibitors
And due to the restoration of homologous recombination repair function, reverse mutation, drug efflux, or mutations in genes involved in other DNA damage repair response mechanisms, it is inevitable that some patients will develop acquired resistance during the treatment of PARP inhibitors. medicine

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Markers for drug resistance of cancer cells, preparation compositions for reversing drug resistance of cancer cells and applications of markers
  • Markers for drug resistance of cancer cells, preparation compositions for reversing drug resistance of cancer cells and applications of markers
  • Markers for drug resistance of cancer cells, preparation compositions for reversing drug resistance of cancer cells and applications of markers

Examples

Experimental program
Comparison scheme
Effect test

experiment example 1

[0044] Experimental example 1 Animal experiment

[0045] NOD-SCID nude mice (female, four weeks old) were purchased from Huafukang Biological Company. Will 1×10 6 Ovarian cancer cells (cancer cell OV2008 (CON, CEBPB) and cancer cell C13* (shCON, shCEBPB (1) and shCEBPB (2)) were mixed with cell PBS and matrigel (Matrigel, purchased from Merck) 0.2ml was inoculated in the armpit of one side of nude mice, and the tumor volume was detected. When the tumor volume reached approximately 200mm 3 start dosing.

[0046] Among them, shCEBPB(1) / shCEBPB(2) is the silencing genotype constructed by CEBPB using a lentiviral vector, and shCON is the silencing gene control type, see the attached figure. In this experiment example, the lentivirus purchased from Jikai Gene (China) was used to silence or overexpress C / EBPβ, and the puromycin resistance gene was inserted when constructing the lentiviral vector, which was used for selection by adding puromycin after transfection. The stably tra...

experiment example 4

[0059] Experimental example 4 promoter luciferase reporter gene experiment

[0060] Routinely, an appropriate amount of cells to be transfected is planted in a six-well plate, and the transfection is performed when the cells adhere to the wall and reach about 60% confluency. About 2 μg of firefly luciferase reporter plasmid (carrying the promoters of the genes of interest (BRCA1, BRIP1, BRIT1, and RAD51), Qingke Biological Co., Ltd.) was transfected in each well, and the Renilla luciferase reporter plasmid pRL-TK was used as the Reference plasmid (does not carry the promoter of the target gene, Viking Biotechnology Co., Ltd.). Using transfection reagent (lipofectamine TM 3000, Thermo Scientific Universal Transfection Reagent) for double transfection, and 24 hours after transfection, firefly luciferase reporter gene detection kit (Dual- Reporter Assay System) for promoter luciferase reporter gene experiment.

experiment example 5We

[0061] Experimental example 5 Western blot detection of protein expression

[0062] Add RIPA Lysis Buffer (purchased from Sewell) to the cell culture medium to be tested for lysis, and use Coomassie Brilliant Blue solution to determine the protein concentration. After adding the protein loading buffer and mixing well, the protein sample was boiled at 100°C for 5 minutes. 10% SDS-PAGE gel was used for electrophoresis, PVDF membrane was transferred, and then blocked with TBST solution containing 5% BSA for 1 hour at room temperature. According to the molecular weight of the target protein, the membrane was cut into several strips and incubated with the primary antibody at 4°C overnight. The next day, the strips were rewarmed and washed three times with TBST for 10 min each time, and incubated with the corresponding secondary antibody at room temperature for 1 hour. Then rinse with TBST for 3 times, 10 min each time, then use ECL developer to develop color. A Bio-rad exposure ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to markers for drug resistance of cancer cells, preparation compositions for reversing drug resistance of cancer cells and applications of the markers. The markers are a CEBPB gene and C / EBP beta protein expressed by the CEBPB gene. The CEBPB gene and the protein thereof regulate DNA damage repair signals of cancer cells. According to the invention, the C / EBP beta-mediated PARP inhibitor is drug-resistant and is a key regulatory factor of a homologous recombination repair pathway. HRD can be induced through C / EBP beta targeted therapy, so that the sensitivity of cancer cells to the PARP inhibitor is correspondingly recovered, thereby reducing or relieving acquired drug resistance of the PARP inhibitor.

Description

technical field [0001] The invention relates to the technical field of biomedicine, in particular to markers of drug resistance of cancer cells, a combination of preparations for reversing drug resistance of cancer cells and applications thereof. Background technique [0002] Ovarian cancer cells have highly unstable genomes with prevalent inherited or acquired genetic mutations in their distinct DNA damage repair pathways. In order to maintain the stability of the genome, biological evolution has formed a complex DNA damage repair response mechanism to deal with widespread endogenous or exogenous genotoxic damage. The DNA damage repair response mechanism consists of a series of interconnected signaling pathways. There are three repair methods for DNA single-strand breaks, namely base excision repair, nucleic acid excision repair and mismatch repair. DNA double-strand breaks are more toxic to cells and difficult to repair. The body relies on two pathways, homologous recom...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/12C07K14/82C12Q1/6886G01N33/574A61K45/06A61P35/00
CPCC07K14/82C12Q1/6886G01N33/57484A61K45/06A61P35/00C12Q2600/158
Inventor 高庆蕾马丁谭佳鸿刘眈夏宇
Owner TONGJI HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI TECH